MEKINIST is a kinase inhibitor indicated as a single agent and in combination with dabrafenib for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. The use in combination is based on the demonstration of durable response rate. Improvement in disease-related symptoms or overall survival has not been demonstrated for MEKINIST in combination with dabrafenib
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of MEKINIST (trametinib) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the MEKINIST (trametinib) tablets medicine cost price in India.
The order for MEKINIST (trametinib) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Trametinib may be used alone or in combination with another medication (dabrafenib) to treat a type of skin cancer (melanoma). It is also used with dabrafenib to treat thyroid cancer and a type of lung cancer (non-small cell lung cancer-NSCLC). Trametinib works by slowing the growth of cancer cells.
MEKINIST (trametinib) tablets, for oral use Initial U.S. Approval: 2013
Generic Name: trametinib
Tablets: 0.5 mg, 1 mg, and 2 mg
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand MEKINIST (trametinib) tablets on prescription and Import License in Patient's Name only.
For overseas patients, MEKINIST (trametinib) tablets can be made available in Send your enquiry to find MEKINIST (trametinib) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For MEKINIST (trametinib) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Long-term survival benefit shown for metastatic melanoma patients treated with Novartis Tafinlar® + Mekinist® For More Details
FDA approves Tafinlar-Mekinist combination for BRAF-mutated anaplastic thyroid cancer For More Details